Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omegaven for Parenteral Nutrition Associated Cholestasis
NCT03662282Phase 3Completed
- Sponsor
- University of South Florida
- Start
- Oct 2018
- Primary completion
- Jan 2019
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid in parenteral nutrition-associated cholestasis (PNAC), sponsored by University of South Florida. Started Oct 2018; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
parenteral nutrition-associated cholestasis (PNAC)
Beyond the preview
Go deeper on NCT03662282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03662282.